T he National Institute for Occupational Safety and Health ([NIOSH], 2004) defines hazardous drugs (HDs) as inherently toxic drugs posing a risk to healthcare providers. They are characterized as having carcinogenicity, teratogenicity, reproductive toxicity, genotoxicity, and organ toxicity at low doses. Nurses comprise the largest proportion of healthcare providers who make contact with HDs during multiple types of clinical activities (Connor & McDiarmid, 2006 Polovich et al. (2014) are based on a five-level, pyramid-shaped Hierarchy of Controls that can be followed by administrators and nurses. The top level of the pyramid involves reducing drug toxicity to control the risk from exposure, but this is generally not feasible in clinical practice. The remaining levels in the pyramid are similarly ranked, from most effective to least effective, according to how effective they are at controlling exposure: engineering controls, administrative controls, work practice controls, and personal protective equipment (PPE). Engineering controls reduce exposure through the use of equipment like biologic safety cabinets when preparing HDs and closed-system transfer devices when preparing and administering HDs. Administrative controls consist of policies and procedures for safe HD handling put in place by hospital management, regular updates to HD lists, education and training, medical surveillance, 
